I agree that CAN will likely go belly up because it is saddled by huge debt burden >$65m & is still a cash burner. BXN certainly ran ahead of itself , but it seems that the market see it differently from the vertically integrated businesses like CAN , LGP & ECS that require large CAPEX & OPEX to maintain theiir cultivation & processing/manufacturing assets making them vulnerable if they can't sell enough of their stuff. BXN is a scalable , low capital business. I reckon this why it is attracting a much larger premium, but I believe this is too much of a premium. -------- The wild card (pure speculation) is BXN dormant Direct Sale business that one day may be reactivated in Australia & NZ for sale of low dose gummies. Nam Hoat Chua retired as joint CEO , but he is probably still involved with the direct sale business & he is a large holder in BXN.
BXN Price at posting:
3.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
